S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
California authorizes expansion of Waymo's driverless car services to LA, SF peninsula
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
College athletes will need school approval for NIL deals under bill passed by Utah Legislature
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
California authorizes expansion of Waymo's driverless car services to LA, SF peninsula
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
College athletes will need school approval for NIL deals under bill passed by Utah Legislature
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
California authorizes expansion of Waymo's driverless car services to LA, SF peninsula
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
College athletes will need school approval for NIL deals under bill passed by Utah Legislature
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
California authorizes expansion of Waymo's driverless car services to LA, SF peninsula
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
College athletes will need school approval for NIL deals under bill passed by Utah Legislature
OTCMKTS:IGXT

IntelGenx Technologies (IGXT) Stock Price, News & Analysis

$0.16
0.00 (0.00%)
(As of 03/1/2024 ET)
Today's Range
$0.15
$0.17
50-Day Range
$0.13
$0.18
52-Week Range
$0.09
$0.26
Volume
196,935 shs
Average Volume
59,441 shs
Market Capitalization
$27.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

IGXT stock logo

About IntelGenx Technologies Stock (OTCMKTS:IGXT)

IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 and INT0055/2021 are for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0053/2020, and INT0054/2020. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was incorporated in 1999 and is headquartered in Montreal, Canada.

IGXT Stock Price History

IGXT Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
IntelGenx Launches Preferred Share Regulation A Offering
IntelGenx Technologies Corp. (IGXT)
Intelgenx Technologies Corp IGXT
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
IntelGenx Reports Third Quarter 2023 Financial Results
IntelGenx Provides RIZAFILM® U.S. Commercialization Update
IntelGenx Reports Second Quarter 2023 Financial Results
IGXT - IntelGenx Technologies Corp.
See More Headlines
Receive IGXT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IntelGenx Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/12/2020
Today
3/02/2024
Next Earnings (Estimated)
3/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:IGXT
CUSIP
45822R101
Employees
4
Year Founded
N/A

Profitability

Net Income
$-10,690,000.00
Net Margins
-1,436.51%
Pretax Margin
-1,436.51%

Debt

Sales & Book Value

Annual Sales
$950,000.00
Book Value
($0.02) per share

Miscellaneous

Free Float
101,214,000
Market Cap
$27.42 million
Optionable
Not Optionable
Beta
2.42
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. André Godin C.A. (Age 60)
    CPA, CA, CPA, President & CFO
    Comp: $242.07k
  • Mr. Tommy Kenny J.D. (Age 37)
    L.L.B., M.Sc., Senior VP & General Counsel
    Comp: $141.21k
  • Ms. Nadine Paiement (Age 47)
    Vice-Chair of Scientific Advisory Board and VP of Research & Development - IntelGenx Corp
    Comp: $151.69k
  • Mr. Dwight Gorham
    Chief Executive Officer
  • Stephen Kilmer
    Investor Relations Officer
  • Ms. Ingrid Zerbe (Age 70)
    Corporate Secretary
  • Zenoz Nina Pourhassan
    VP of Quality Operations of Subsidiary














IGXT Stock Analysis - Frequently Asked Questions

How have IGXT shares performed in 2024?

IntelGenx Technologies' stock was trading at $0.1381 at the beginning of 2024. Since then, IGXT stock has increased by 13.7% and is now trading at $0.1570.
View the best growth stocks for 2024 here
.

Are investors shorting IntelGenx Technologies?

IntelGenx Technologies saw a decrease in short interest in the month of February. As of February 15th, there was short interest totaling 30,800 shares, a decrease of 7.5% from the January 31st total of 33,300 shares. Based on an average daily volume of 143,600 shares, the days-to-cover ratio is currently 0.2 days.
View IntelGenx Technologies' Short Interest
.

When is IntelGenx Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 27th 2024.
View our IGXT earnings forecast
.

How were IntelGenx Technologies' earnings last quarter?

IntelGenx Technologies Corp. (OTCMKTS:IGXT) announced its quarterly earnings results on Thursday, November, 12th. The company reported ($0.01) EPS for the quarter, topping analysts' consensus estimates of ($0.02) by $0.01. The business had revenue of $0.51 million for the quarter.

What other stocks do shareholders of IntelGenx Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IntelGenx Technologies investors own include Cronos Group (CRON), Zevra Therapeutics (KMPH), Exelixis (EXEL), SemiLEDs (LEDS), New Residential Investment (NRZ), Anavex Life Sciences (AVXL), BioDelivery Sciences International (BDSI), BIOLASE (BIOL) and Ocugen (OCGN).

How do I buy shares of IntelGenx Technologies?

Shares of IGXT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:IGXT) was last updated on 3/2/2024 by MarketBeat.com Staff